Ethris and DZIF Form Strategic Partnership to Advance Development of mRNA-Based Vaccines
Ethris and German Center for Infection Research (DZIF) Announce Strategic Collaboration to Develop mRNA-Based Vaccines Ethris GmbH, a clinical-stage biotechnology company pioneering next-generation RNA therapeutics and vaccines, and the German Center…
Median Technologies Achieves FDA Clearance for Groundbreaking AI Lung Cancer Screening Technology
Median Technologies Receives FDA 510(k) Clearance for eyonis® LCS, the First AI Tech-Based Detection and Diagnosis Device for Lung Cancer Screening Median Technologies developer of eyonis®, a suite of artificial intelligence…
Evinova and Bristol Myers Squibb Partner Strategically to Enhance Clinical Development Using AI
Evinova and Bristol Myers Squibb Forge Strategic Collaboration to Optimize Clinical Development with Artificial Intelligence Evinova today announced that Bristol Myers Squibb has signed an agreement to optimize clinical trials…
Fenebrutinib by Genentech Marks Major Breakthrough in Treating Primary Progressive Multiple Sclerosis
Genentech’s Fenebrutinib Is the First Investigational Medicine in Over a Decade That Reduces Disability Progression in Primary Progressive Multiple Sclerosis (PPMS) Genentech, a member of the Roche Group announced today…
Roche’s Fenebrutinib Shows First PPMS Disability Reduction in Over a Decade
Roche’s fenebrutinib becomes the first investigational therapy in over a decade to slow disability progression in primary progressive multiple sclerosis (PPMS) Roche announced today new late-breaking data from the Phase…
Dr. Joseph Chang Unveils Expanded Edition of The Aging Myth
Dr. Joseph Chang Launches Update to Bestselling Book “The Aging Myth” With 15 More Years of Breakthrough Research on Cellular Wellness Nu Skin Enterprises Inc. today announced the relaunch of…
Johnson & Johnson Shares Early OMNY-AF Pilot Study Results at the 2026 AF Symposium
Johnson & Johnson Presents Early Outcomes from the OMNY-AF Pilot Study at 2026 AF Symposium Johnson & Johnson today announced 12-month pilot-phase data from the OMNY-AF study, evaluating the investigational…
Rapid Medical’s DISTALS Trial Shows Strong Results, Highlighting Superior Reperfusion with TIGERTRIEVER™ 13
Rapid Medical’s DISTALS Trial Overwhelmingly Positive, Demonstrating Superior Reperfusion with TIGERTRIEVER™ 13 in Medium Vessel Stroke Rapid Medical™, a leading developer of active endovascular devices, today announced late-breaking results from…
Celebrating 24 Years of Give Kids A Smile: A Lasting Legacy of Brighter Smiles
A Legacy of Brighter Smiles: Celebrating 24 Years of the Give Kids A Smile Program The American Dental Association Foundation (ADAF) is officially kicking off Give Kids A Smile® (GKAS) 2026…
Applied Medical Wins Antitrust Jury Trial Against Medtronic
Applied Medical Prevails in Antitrust Jury Trial Against Medtronic Applied Medical announced today a significant legal victory that should help open the healthcare market to innovation and lower costs. A…
Supplemental Screening Program Celebrates 20 Years, Urges Eligible Individuals to Join
National Supplemental Screening Program Celebrates 20 Years of Service; Eligible Individuals Encouraged to Participate The U.S. Department of Energy (DOE) National Supplemental Screening Program (NSSP), managed by ORAU, is celebrating…
Mainstay Medical Secures Exclusive Blue Cross Blue Shield of North Dakota Coverage for ReActiv8®
Mainstay Medical Announces Exclusive Coverage of ReActiv8® by Blue Cross Blue Shield of North Dakota Mainstay Medical Holdings plc today announced that Blue Cross Blue Shield of North Dakota has…